Arrowhead Pharmaceuticals · 8 hours ago
Associate Director, R&D Financial Planning & Analysis
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. The Associate Director, R&D Financial Planning & Analysis will support the R&D organization in budget preparation, forecasts, and strategic investments while collaborating with various stakeholders to influence decision-making and ensure effective clinical portfolio execution.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Lead the annual operating plan, rolling forecasts, and long-range financial planning processes for the R&D organization
Support strategic initiatives such as pipeline investment decisions, external collaborations, and business development evaluations
Act as a trusted advisor to senior leaders, translating operational plans into financial implications
Analyze actual results versus plan and forecast, clearly communicating key drivers and emerging trends
Support clinical trial budgeting, forecasting, and accrual analysis, including CRO spend, investigator grants, patient costs, and pass-through expenses
Monitor clinical program spend versus plan, identifying risks, opportunities, and timing impacts
Partner with Clinical Operations, Program Management, and Accounting to ensure accurate forecasting, spend visibility, and financial close alignment
Support portfolio-level decision-making, including program prioritization, scenario analysis, and development trade-offs
Review, evaluate, and support negotiation of CRO and clinical vendor agreements, including study budgets, change orders, and contract amendments, to ensure cost efficiency, appropriate risk sharing, and alignment with development plans
Provide financial diligence on clinical vendor proposals, assessing pricing structures, payment terms, scope assumptions, and financial risks in partnership with Legal, Procurement, and Clinical Operations
Enhance financial transparency and decision support through dashboards and executive-ready materials
Develop and track KPIs related to R&D efficiency, clinical execution, and overall financial performance
Recommend actions to improve cost discipline, forecast accuracy, and resource utilization
Lead enhancements to FP&A processes, models, and planning tools
Drive best practices in forecasting, scenario planning, and financial reporting
Partner with Accounting and IT on ERP and FP&A system optimization
Lead, mentor, and develop the R&D FP&A and Clinical Finance teams, fostering a high-performing, collaborative culture
Establish clear expectations, accountability, and professional development paths
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or related field
10+ years of progressive FP&A experience, including 5+ years in a leadership role
Highly proficient in Microsoft Excel, with experience building models
Ability to gather, analyze and interpret information for completeness and accuracy; excellent attention to detail; excellent organizational skills
Strong communication skills, ability to effectively interact with others at all levels– within and outside of finance. Ability to tailor communication to the audience to achieve desired results
Self-starter with the demonstrated ability to work in a fast-paced atmosphere with minimal supervision
Working knowledge of Generally Accepted Accounting Principles (US GAAP)
Preferred
CPA/MBA
Experience with FP&A Planning systems (Anaplan experience a plus)
Experience with building financial models
Experience with Microsoft Dynamics 365 and BI tools (e.g. Tableau, Power BI)
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
Company data provided by crunchbase